Medicine
Pifeltro 100 mg tablet
Pifeltro 100 mg tablet is a prescription medicine containing Doravirine for oral use, marketed by Merck Sharp & Dohme, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store PIFELTRO at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to…
Key facts
- Active ingredient (INN)
- Doravirine
- Brand
- Pifeltro
- Strength
- 100 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets
- Marketing authorisation holder
- Merck Sharp & Dohme
- Manufacturers
- Merck Sharp & DohmeA-S Medication Solutions
- Origin register
- US FDA, United States
- Storage
- Store PIFELTRO at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F). Store PIFELTRO in the original bottle. Keep the bottle tightly closed to protect from moisture.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J05AG06 Doravirine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 20 July 2018
- Identifiers
- RxCUI 2055760, 2055766DailyMed set ID 76ce1f00-28c0-4314-bd2c-d473fe3d0970, ff06e5cc-f47a-4779-816b-0e5b13e88a25NDC 0006-3069, 50090-6268Application NDA210806
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet, film coated in 1 bottle | 0006-3069-01 | Merck Sharp & Dohme | 20 July 2018 |
| 30 tablet, film coated in 1 bottle | 50090-6268-0 | A-S Medication Solutions | 13 December 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Doravirine is a human immunodeficiency virus 1 non-nucleoside analog reverse transcriptase inhibitor indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 35 kg. MedsAcross supplies Doravirine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DoravirineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- PIFELTRO prescribing information (Merck Sharp & Dohme) · U.S. National Library of Medicine, DailyMed
- Pifeltro: European public assessment report (EPAR) · European Medicines Agency
Need Pifeltro 100 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.